Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
#Continuous Renal Replacement Therapy Market Size Outlook: How Quickly Will Revenue Expand Through 2030?#_x000D_
The continuous renal replacement therapy market size has experienced significant expansion in recent years. It will grow from $1.73 billion in 2025 to $1.92 billion in 2026 at a compound annual growth rate (CAGR) of 10.8%. This historical expansion is primarily due to the increasing incidence of acute kidney injury in critical care, a rise in ICU admissions for conditions like sepsis and multi-organ failure, the expanding use of renal support therapies, improvements in critical care infrastructure, and the enhanced survival of critically ill patients._x000D_
_x000D_
The continuous renal replacement therapy market is anticipated to experience substantial expansion over the upcoming years. By 2030, this market is projected to reach $2.77 billion, demonstrating a compound annual growth rate (CAGR) of 9.6%. This anticipated growth during the forecast period stems from factors such as an aging demographic prone to increased AKI risk, the escalating prevalence of critical illnesses, the wider embrace of advanced renal support technologies, an enhanced emphasis on personalized critical care approaches, and the expansion of intensive care capabilities in developing regions. Key trends identified for the forecast period encompass the increasing integration of CRRT within intensive care units, a greater utilization of continuous therapies for patients with hemodynamic instability, the heightened need for precise fluid and electrolyte management, the broader application of CRRT in pediatric and neonatal settings, and a growing inclination towards integrated CRRT systems and their associated consumables._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Continuous Renal Replacement Therapy Market Demand Drivers: What’s Powering Industry Growth?#_x000D_
The rising occurrence of chronic kidney diseases is projected to stimulate the advancement of the continuous renal replacement therapy market moving forward. Chronic Kidney Disease (CKD) is a persistent ailment where the kidneys gradually lose their functional capacity over time, leading to inefficient filtration of waste products from the blood. The growing prevalence of chronic kidney diseases is influenced by evolving lifestyle choices, an aging global population, and increasing rates of diabetes and hypertension. Continuous renal replacement therapy is employed in cases of chronic kidney disease during acute flare-ups or complications, aiming to regulate fluid balance and consistently clear metabolic waste products. For instance, in May 2024, as reported by the Centers for Disease Control and Prevention, a U.S.-based national public health agency, an estimated more than 1 in 7 adults in the US, exceeding 35.5 million people, live with chronic kidney disease (CKD). Importantly, almost 90% of these individuals are unaware of their condition, which points to a considerable deficit in early detection and awareness campaigns for CKD within the US. Hence, the increasing incidence of chronic kidney diseases is propelling the growth of the continuous renal replacement therapy market._x000D_
_x000D_
#Continuous Renal Replacement Therapy Market Segmentation: How Does The Market Break Down By Category?#_x000D_
The continuous renal replacement therapy market covered in this report is segmented – _x000D_
_x000D_
1) By Product: System, Consumables_x000D_
2) By Therapy: Renal, Non-Renal_x000D_
3) By Modality: Slow Continuous Ultra-Filtration (SCUF), Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodialysis (CVVHD), Continuous Venovenous Hemodiafiltration (CVVHDF)_x000D_
4) By Age Group: Adults, Pediatrics Or Neonates_x000D_
5) By End-Users: Hospitals, Ambulatory Care_x000D_
_x000D_
Subsegments:_x000D_
1) By System: Hemofilters, CRRT Machines, Blood Tubing Sets_x000D_
2) By Consumables: Dialysate Solutions, Replacement Fluids, Catheters, Bloodline Sets_x000D_
_x000D_
#Continuous Renal Replacement Therapy Market Innovation Trends: What Developments Are Reshaping The Industry?#_x000D_
Companies operating in the continuous renal replacement therapy market are concentrating on developing innovative renal therapy alternatives for dialysis patients to enhance treatment effectiveness, improve patient outcomes, and mitigate complications associated with traditional dialysis methods. This advanced therapy operates continuously, typically over 24 hours, and is gentler on the body compared to standard dialysis, making it well-suited for patients with acute kidney injuries or severe health conditions. For instance, in January 2023, Peconic Bay Medical Center (PBMC), a US-based medical center offering various services including emergency and surgical care, launched a new renal therapy option for dialysis patients, as per a report it published. This therapy is designed to provide greater comfort for patients who might not tolerate standard dialysis due to their medical conditions. CRRT is administered more slowly than traditional dialysis, which helps minimize stress on critically ill patients._x000D_
_x000D_
#Continuous Renal Replacement Therapy Market Leading Players And Competitive Positioning#_x000D_
Major companies operating in the continuous renal replacement therapy market are Medtronic Plc, Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, NxStage Medical Inc., Gambro AB, JMS Co. Ltd., Quanta Dialysis Technologies Ltd., Bellco S.r.l., Ningbo Tianyi Medical Devices Co. Ltd., Kawasumi Laboratories Inc., Medica S.p.A., Infomed SA, Nikkiso Co. Ltd., Anjue Medical Equipment Co. Ltd., Toray Medical Co. Ltd., Kawasumi Hemofiltration Inc. _x000D_
_x000D_
#View The Full Continuous Renal Replacement Therapy Market Report:#_x000D_
_x000D_
#Continuous Renal Replacement Therapy Market Regional Distribution: Which Areas Power Market Growth?#_x000D_
North America was the largest region in the continuous renal replacement therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the continuous renal replacement therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.